These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11354383

  • 41. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L, Haj-Dahmane S, Hamon M.
    Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017
    [Abstract] [Full Text] [Related]

  • 42. Acute rise in corticosterone facilitates 5-HT(1A) receptor-mediated behavioural responses.
    Meijer OC, Kortekaas R, Oitzl MS, de Kloet ER.
    Eur J Pharmacol; 1998 Jun 12; 351(1):7-14. PubMed ID: 9698199
    [Abstract] [Full Text] [Related]

  • 43. Animal models for studying serotonin (5-HT) receptor subtypes: relationship to 5-HT system pathologies.
    Ogren SO, Misane I.
    Nucl Med Biol; 1998 Nov 12; 25(8):747-9. PubMed ID: 9863561
    [Abstract] [Full Text] [Related]

  • 44. Structure-activity relationship studies of CNS agents, Part 32: Effect of structural modifications in 1-arylpiperazine derivatives on alpha(1) -adrenoreceptor affinity.
    Mokrosz MJ, Paluchowska MH, Charakchieva-Minol S, Bień A.
    Arch Pharm (Weinheim); 1997 Jun 12; 330(6):177-80. PubMed ID: 9264242
    [Abstract] [Full Text] [Related]

  • 45. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 12; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 46. 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists.
    Moore NA, Rees G, Sanger G, Perrett L.
    Pharmacol Biochem Behav; 1993 Sep 12; 46(1):141-3. PubMed ID: 8255903
    [Abstract] [Full Text] [Related]

  • 47. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 12; 275(2):822-31. PubMed ID: 7473172
    [Abstract] [Full Text] [Related]

  • 48. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
    Borsini F, Ceci A, Bietti G, Donetti A.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep 12; 352(3):283-90. PubMed ID: 8584043
    [Abstract] [Full Text] [Related]

  • 49. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
    Kulikov AV, Kolpakov VG, Maslova GB, Kozintsev I, Popova NK.
    Psychopharmacology (Berl); 1994 Feb 12; 114(1):172-4. PubMed ID: 7846200
    [Abstract] [Full Text] [Related]

  • 50. Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats.
    Carli M, Bonalumi P, Samanin R.
    Eur J Neurosci; 1998 Jan 12; 10(1):221-30. PubMed ID: 9753130
    [Abstract] [Full Text] [Related]

  • 51. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG, Beneytez ME, Delgado M, Manzanares J, López-Rodríguez ML, Benhamu B, Morcillo MJ, Pozo MA, Rubia FJ, Fuentes JA.
    Pharmacology; 2001 May 12; 62(4):234-42. PubMed ID: 11360001
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Ligand-5-HT1A receptor interaction.
    Chilmonczyk Z.
    Farmaco; 2000 Mar 12; 55(3):191-3. PubMed ID: 10919079
    [Abstract] [Full Text] [Related]

  • 56. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun 12; 355(6):682-8. PubMed ID: 9205951
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ, Van Gompel P, Leysen JE.
    Biochem Pharmacol; 1993 Jan 26; 45(2):375-83. PubMed ID: 8382063
    [Abstract] [Full Text] [Related]

  • 60. 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats.
    Cervo L, Samanin R.
    Pharmacol Biochem Behav; 1995 Dec 26; 52(4):671-6. PubMed ID: 8587903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.